Lucy Scientific Discovery Inc. LSDIF
OTC PK
| 09/30/2023 | 06/30/2023 | 06/30/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 82.27% | 136.67% | 136.67% | -41.26% | 15.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 82.27% | 137.18% | 137.18% | -41.26% | 15.97% |
| Operating Income | -82.27% | -136.38% | -136.38% | 41.26% | -15.97% |
| Income Before Tax | -45.67% | -96.25% | -96.25% | 39.08% | -2.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.67% | -96.25% | -96.25% | 39.08% | -2.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.67% | -96.25% | -96.25% | 39.08% | -2.36% |
| EBIT | -82.27% | -136.38% | -136.38% | 41.26% | -15.97% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 13.48% | -25.43% | -25.43% | 40.85% | 36.52% |
| Normalized Basic EPS | 17.68% | -21.78% | -21.78% | 40.86% | 36.52% |
| EPS Diluted | 13.48% | -25.43% | -25.43% | 40.85% | 36.52% |
| Normalized Diluted EPS | 17.68% | -21.78% | -21.78% | 40.86% | 36.52% |
| Average Basic Shares Outstanding | 68.34% | 56.45% | 56.45% | 3.00% | 61.25% |
| Average Diluted Shares Outstanding | 68.34% | 56.45% | 56.45% | 3.00% | 61.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |